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Abstract
Objectives: Pulse wave velocity (PWV) is a surrogate end-point for cardiovascular morbidity and mortality. A plasma glucose
value $155 mg/dl for the 1-hour post-load plasma glucose during an oral glucose tolerance test (OGTT) is able to identify
subjects with normal glucose tolerance (NGT) at high-risk for type-2 diabetes (T2D) and for subclinical organ damage. Thus,
we addressed the question if 1-hour post-load plasma glucose levels, affects PWV and its central hemodynamic correlates,
as augmentation pressure (AP) and augmentation index (AI).
Methods: We enrolled 584 newly diagnosed hypertensives. All patients underwent OGTT and measurements of PWV, AP
and AI. Insulin sensitivity was assessed by Matsuda-index.
Results: Among participants, 424 were NGT and 160 had impaired glucose tolerance (IGT). Of 424 NGT, 278 had 1-h post-
load plasma glucose ,155 mg/dl (NGT,155) and 146 had 1-h post-load plasma glucose $155 mg/dl (NGT$155).
NGT$155 had a worse insulin sensitivity and higher hs-CRP than NGT,155, similar to IGT subjects. In addition, NGT$155 in
comparison with NGT,155 had higher central systolic blood pressure (134612 vs 131610 mmHg), as well as PWV (8.463.7
vs 6.761.7 m/s), AP (12.567.1 vs 9.865.7 mmHg) and AI (29.4611.9 vs 25.1612.4%), and similar to IGT. At multiple
regression analysis, 1-h post-load plasma glucose resulted the major determinant of all indices of vascular stiffness.
Conclusion: Hypertensive NGT$155 subjects, compared with NGT,155, have higher PWV and its hemodynamic correlates
that increase their cardiovascular risk profile.
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Introduction
Abnormal arterial stiffness, which usually develops with aging, is
associated with increased risk for various adverse outcomes,
including cardiovascular disease [1,2], stroke [2,3], and renal
disease [4]. Arterial stiffness also increases in subjects with
traditional cardiovascular risk factors suggesting, in addition to
a background effect of aging per se, the effect of the exposure of
the vessel wall to the cardiovascular risk factors, including
hypertension, obesity, impaired glucose tolerance (IGT), and
dyslipidemia [5]. In addition, there are some evidences demon-
strating that arterial stiffness is associated with an important
disparity between peripheral and aortic blood pressure (BP);
particularly, several evidences suggest that aortic BP and its
indices, such as augmentation pressure (AP) and augmentation
index (AI), correlate more closely with intermediate markers of
cardiovascular risk than brachial BP [6].
On the other hand, it’s known that type-2 diabetes mellitus
(T2D) is an independent risk factor for heart failure even in
absence of coronary artery disease or hypertension [7]. In
addition, subjects with IGT and/or impaired fasting glucose
(IFG) are characterized by an unfavorable cardiovascular risk
profile [8].
Although normoglucose tolerant (NGT) subjects are considered
at very low cardiovascular risk, recently a cutoff point of 155 mg/
dl for the one-hour (1-h) post-load plasma glucose, during an oral
glucose tolerance test (OGTT), was able to identify NGT subjects
at high risk for T2D [9]. Moreover, 1-hour post-load plasma
glucose value $155 mg/dl is strongly associated with different
subclinical organ damages [10–13] that are independent pre-
dictors for cardiovascular events [7,8,14].
Taken together, we designed this study to address the question if
glucose tolerance status, and in particular 1-h post-load plasma
glucose levels, may affect arterial stiffness, evaluated by using
applanation tonometry, in a group of never treated hypertensive
Caucasian subjects.
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Methods
Study Population
The study group consisted of 584 uncomplicated hypertensive
outpatients, 322 men and 262 women aged 35–65 years
(mean6SD=46.569.8), participating to the CAtanzaro MEta-
bolic RIsk factors Study (CATAMERIS). All patients were
Caucasian and underwent physical examination and review of
their medical history. Causes of secondary hypertension were
excluded by appropriate clinical and biochemical tests. Other
exclusion criteria were history or clinical evidence of coronary and
valvular heart disease, congestive heart failure, hyperlipidemia,
peripheral vascular disease, chronic gastrointestinal diseases
associated with malabsorption, chronic pancreatitis, history of
any malignant disease, history of alcohol or drug abuse, liver or
kidney failure and treatments able to modify glucose metabolism.
No patient had ever been treated with antihypertensive drugs. All
subjects underwent anthropometrical evaluation: weight, height,
and body mass index (BMI).
After 12-h fasting, a 75 g OGTT was performed with 0, 30, 60,
90 and 120 minutes sampling for plasma glucose and insulin.
Glucose tolerance status was defined on the basis of OGTT using
the World Health Organization (WHO) criteria. Insulin sensitivity
was evaluated using the Matsuda index [insulin sensitivity index
(ISI)], calculated as follows: 10,000/square root of [fasting glucose
(millimoles per liter)6fasting insulin (milliunits per liter)]*[mean
glucose * mean insulin during OGTT]. The Matsuda index is
strongly related to euglycemic hyperinsulinemic clamp that
represents the gold standard test for measuring insulin sensitivity
[15]. According to NCEP-ATPIII criteria, we also evaluated the
presence/absence of metabolic syndrome (MS). The Ethical
Committee approved the protocol and informed written consent
was obtained from all participants. All the investigations were
performed in accordance with the principles of the Declaration of
Helsinki.
Blood Pressure Measurements
Readings of clinic blood pressure (BP) were obtained in the left
arm of the supine patients, after 5 min of quiet rest, with a mercury
sphygmomanometer. Minimum three BP readings were taken on
three separate occasions at least 2 weeks apart. Systolic and
diastolic BP was recorded at the first appearance (phase I) and the
disappearance (phase V) of Korotkoff sounds. Baseline BP values
were the average of the last two of the three consecutive
measurements obtained at intervals of 3 minutes. Patients with
a clinic systolic BP (SBP) .140 mmHg and/or diastolic BP (DBP)
.90 mmHg were defined as hypertensive.
Laboratory Determinations
Plasma glucose was measured by the glucose oxidation method
(Beckman Glucose Analyzer II; Beckman Instruments, Milan,
Italy). Triglyceride, total, low- (LDL) and high-density lipoprotein
(HDL) cholesterol concentrations were measured by enzymatic
methods (Roche Diagnostics GmbH, Mannheim, Germany).
Plasma insulin concentration was determined by a chemilumines-
cence-based assay (Roche Diagnostics).
Arterial Wave Reflection and Central BP Measurements
These measurements were obtained by a validated system
(SphygmocorTM; AtCor Medical, Sydney, Australia) that employs
high-fidelity applanation tonometry (Millar) and appropriate
computer software for the analysis of pressure wave (Sphygmo-
corTM). Pressure calibration was obtained through automatically,
non-invasively recorded supine brachial artery BP of the dominant
arm after a 30-minute rest (Dinamap Compact T; Johnson &
Johnson Medical Ltd, Newport, UK). BP was measured five times
over 10 minutes and the mean of the last three measurements were
taken for calibration. Pressure wave recording was performed at
the radial artery of the dominant arm with the wrist softly
hyperextended, and it is the average of single pressure waves
recorded consecutively for eight seconds. Pressure wave recordings
were accepted only if variation of peak and bottom pressures of
single pressure waves was ,5%. The central pressure wave was
automatically derived from the radial pressures by a built-in
generalized transfer function. In addition, was also obtained
pressure wave measurement at the right carotid artery, as it is well
known that central AI may be more accurately derived from this
vascular site [16]. Central waveforms were further analysed to
identify the time to peak/shoulder of the first (T1) and second (T2)
pressure wave components during systole. The pressure at the
peak/shoulder of T1 was identified as outgoing pressure wave
height (P1), the pressure at the peak/shoulder of T2 was identified
as the reflected pressure wave height (P2), either absolutely or as
percent of ejection duration. AP was defined as difference between
P2–P1, and AI as [AP/pulse pressure (PP)] * 100. Aortic pulse
wave velocity (PWV) was determined from carotid and femoral
pressure waveforms. Carotid to femoral transit time (DT) was
computed from the foot-to-foot time difference between carotid
and femoral waveforms. The distance between the surface
markings of the sternal notch and femoral artery was used to
estimate the path length between the carotid and femoral arteries
(L), and PWV computed as L/DT.
Statistical Analysis
Analysis of variance (ANOVA) for clinical and biological data
was performed to test the differences among groups, and the
Bonferroni post hoc test for multiple comparisons was further
performed. Chi-squared test was utilized for categorical variables.
Correlational coefficients were calculated according to Pearson’s
method. Linear regression analysis was performed to correlate
PWV, AP and AI with the following covariates: age, BMI, SBP,
DBP, cholesterol values, fasting and 1-h and 2-h post-load plasma
glucose levels, fasting and 1-h and 2-h post-load insulin, Matsuda
index and high sensitivity C reactive protein (hs-CRP). Sub-
sequently, variables reaching statistical significance and gender,
MS and smoking status, as dichotomic value, were inserted in
a stepwise multivariate linear regression model to determine the
independent predictors of PWV, AP and AI. Correlational analysis
was performed for whole study population and according to the
groups of glucose tolerance. Data are reported as mean6SD.
Differences were assumed to be significant at P,0.05. All
comparisons were performed using the statistical package SPSS
16.0 for Windows (SPSS Inc., Chicago, Illinois, USA).
Results
Study Population
Of 640 subjects examined by OGTT, 56 were diabetic and
were not included in the present analysis. Thus, of 584 remaining
subjects, 278 had 1-h post-load plasma glucose ,155 mg/dl
(NGT,155), 146 individuals had 1-h post-load plasma glucose
$155 mg/dl (NGT$155), and 160 were IGT. Table 1 shows the
demographic, clinical and biochemical characteristics of the study
groups.
There were no significant differences among groups for gender
distribution (P= 0.338), age (P= 0.698), BMI (P= 0.122), total
cholesterol (P = 0.138), and LDL-cholesterol (P = 0.294). On the
contrary, from the first to the third group of glucose tolerance,
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HDL-cholesterol significantly decreased (P= 0.002), while tri-
glyceride (P= 0.041). hs-CRP (P,0.0001), prevalence of MS
(P,0.0001) significantly increased. The prevalence of smokers was
significantly different among groups (P= 0.037). Obviously, a pro-
gressive increase of fasting, 1-h and 2-h post-load glucose, as well
as fasting insulin, parallel to the worsening of glucose tolerance
(P,0.0001), as confirmed by MATSUDA index/ISI. Moreover,
NGT $155 had a significant reduced insulin-sensitivity
(P,0.0001) and an increased hs-CRP values (P,0.0001), when
compared with NGT,155, and a metabolic and inflammatory
profile similar to IGT individuals.
Hemodynamic Parameters
Peripheral and aortic hemodynamic parameters for the study
population, according to glucose tolerance groups, are reported in
table 2. There were no significant differences among groups for
peripheral BP values, central diastolic BP and heart rate
(P = 0.067). On the contrary, from the first to the third group of
glucose tolerance, we observed a significant increase of aortic
systolic BP (P= 0.003) and PP (P,0.0001). Similarly, all indices of
vascular stiffness progressively increased from the first to third
group (P,0.0001). Notably, NGT$155 subjects showed AP, AI
and PWV not significantly different from IGT.
Correlational Analysis
A linear regression analysis was performed to test the correlation
between AP, AI and PWV and different covariates in the whole
study population and in the groups according to glucose tolerance
status.
AP, in the whole population, was significantly correlated with 1-
h post-load glucose (r = 0.411, P,0.0001), 2-h post-load glucose
(r = 0.219, P,0.0001), age (r = 0.173, P,0.0001), hs-CRP
(r = 0.162, P,0.0001), LDL-cholesterol (r = 0.085, P = 0.019),
fasting glucose (r = 0.121, P= 0.002), systolic BP (r = 0.104,
P = 0.006), and total cholesterol (r = 0.096, P= 0.010). In
NGT,155 subjects, AP was significantly correlated with 1-h
post-load glucose (r = 0.319, P,0.0001), age (r = 0.260,
P,0.0001), 2-h post-load glucose (r = 0.137, P= 0.011), total
cholesterol (r = 0.122, P = 0.021) and BMI (r = 0.118, P = 0.024).
In NGT$155 subjects, AP correlated only with 1-h post-load
glucose (r = 0.433, P,0.0001). In IGT patients, AP was correlated
with 1-h post-load glucose (r = 0.370, P,0.0001), systolic BP
(r = 0.256, P= 0.001), age (r = 0.218, P= 0.003) hs-CRP (r = 0.137,
P= 0.042), and 2-h post-load glucose (r = 0.132, P= 0.047).
AI, in the whole population, was significantly correlated with 1-
h post-load glucose (r = 0.401, P,0.0001), age (r = 0.216,
P,0.0001), 2-h post load glucose (r = 0.198, P,0.0001), BMI
(r = 0.090, P = 0.015), fasting plasma glucose (r = 0.133, P = 0,001),
LDL-cholesterol (r = 0.094, P= 0.011), hs-CRP (r = 0.121,
P= 0.002), total cholesterol (r = 0.106, P= 0.005) and triglyceride
(r = 0.075, P= 0.035), and 2-h post-load insulin (r = 0.099,
P= 0.008). In NGT,155 subjects, AI was significantly correlated
with 1-h post-load glucose (r = 0.288, P,0.0001), age (r = 0.266,
P,0.0001), 2-h post-load glucose (r = 0.128, P= 0.016), BMI
(r = 0.124, P= 0.018), total cholesterol (r = 0.116, P= 0.026) and
fasting glucose (r = 0.105, P = 0.040). In NGT$155 subjects, AI
correlated with 1-h post-load glucose (r = 0.493, P,0.0001), SBP
(r = 0.150, P= 0.035) and LDL-cholesterol (r = 0.143, P = 0.043).
In IGT patients, AI was correlated with 1-h post-load glucose
(r = 0.402, P,0.0001), age (r = 0.237, P = 0.001), BMI (r = 0.139,
P= 0.040), fasting insulin (r = 0.196, P= 0.007, and 1-h post-load
insulin insulin (r = 0.162, P = 0.020).
PWV, in the whole population, was significantly correlated with
1-h post-load glucose (r = 0.503, P,0.0001), hs-CRP (r = 0.294,
P,0.0001), 2-h post load plasma insulin (r = 0.243, P,0.0001), 1-
h post-load plasma insulin (r = 0.200, P,0.0001), 2-h post-load
glucose (r = 0.212, P,0.0001), age (r = 0.171, P,0.0001), fasting
insulin (r = 0.156, P,0.0001), fasting glucose (r = 0.215,
P,0.0001), systolic BP (r = 0.101, P = 0.007), LDL-cholesterol
(r = 0.097, P= 0.010), total cholesterol (r = 0.111, P = 0.004). In
Table 1. Anthropometric and biochemical characteristics of the study population according to glucose tolerance status.
All NGT,155 NGT$155 IGT P
Variables (n =584) (n =278) (n =146) (n =160)
Gender, male/female 322/262 147/131 88/58 87/73 0.338*
Age, years 46.569.8 46.3611.1 46.4610.1 47.166.5 0.698
BMI, Kg/m2 28.563.9 28.364.2 28.663.8 29.163.5 0.122
Fasting glucose, mg/dl 93.8610.9 90.569.2 95.269.1 98.3613.1 ,0.0001
1-h glucose, mg/dl 153.3641.2 120.8622.3 182.2625.5 183.4635.4 ,0.0001
2-h glucose, mg/dl 122.7629.2 103.9619.1 117.5615.3 160.1615.7 ,0.0001
Fasting insulin, mU/ml 12.265.9 10.464.1 13.365.8 14.567.4 ,0.0001
1-h insulin, mU/ml 111.2672.1 88.9655.7 156.1695.1 109.9653.5 ,0.0001
2-h insulin, mU/ml 94.4665.9 60.5635.5 108.3661.9 138.5677.1 ,0.0001
MATSUDA index/ISI 68.6640.7 86.5642.7 54.8631.2 50.9631.6 ,0.0001
Total cholesterol, mg/dl 206.1637.1 205.5636.7 202.2634.1 210.5639.7 0.138
HDL-cholesterol, mg/dl 49.3611.7 51.1612.1 47.4610.2 48.0611.8 0.002
LDL-cholesterol, mg/dl 130.3633.3 129.4632.4 128.2633.2 133.7634.9 0.294
Triglyceride, mg/dl 133.1671.3 126.4672.4 133.7668.3 144.2670.9 0.041
MS, n (%) 271(46.4) 99(35.6) 72(49.4) 100(62.5) ,0.0001*
hs-CRP, mg/L 2.961.8 2.261.4 3.461.8 3.661.9 ,0.0001
Current smokers, n(%) 170(29.1) 84(30.2) 28(19.2) 48(30.0) 0.037*
doi:10.1371/journal.pone.0044470.t001
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NGT,155 subjects, PWV was significantly correlated with 1-h
post-load glucose (r = 0.328, P,0.0001), age (r = 0.229,
P,0.0001), 2-h post-load glucose (r = 0.194, P= 0.001), hs-CRP
(r = 0.177, P= 0.002), 1-h post-load insulin (r = 0.147, P= 0.007)
and total cholesterol (r = 0.140, P = 0.010). In NGT$155 subjects,
PWV was significantly correlated with 1-h post-load glucose
(r = 0.570, P,0.0001), hs-CRP (r = 0.282, P,0.0001), 2-h post-
load insulin (r = 0.219, P= 0.004), age (r = 0.176, P= 0.017), SBP
(r = 0.176, P = 0.017), fasting insulin (r = 0.160, P= 0.027), fasting
plasma glucose (r = 0.160, P= 0.026), 1-h post-load insulin
(r = 0.148, P= 0.037), and Matsuda (r =20.191, P= 0.010).
,0.0001), 2-h post-load insulin (r = 0.234, P = 0.022) and LDL-
cholesterol (r = 0.221, P= 0.029). In IGT patients, PWV was
correlated with 1-h post-load glucose (r = 0.480, P,0.0001),
triglyceride (r = 0.249, P= 0.001) hs-CRP (r = 0.179, P= 0.012),
2-h post-load glucose (r = 0.138, P= 0.041), fasting glucose
(r = 0.214, P= 0.003), total cholesterol (r = 0.173, P= 0.014) and
age (r = 0.154, P= 0.026).
Thus, variables reaching statistical significance, and gender, MS
and smoking status, as dichotomic values, were inserted in
a stepwise multivariate linear regression model to determine the
independent predictors of AP, AI and PWV (Tables 3, 4, and 5),
respectively. This analysis was performed in the total population
and according to glucose tolerance status. In whole population, 1-
h post-load glucose and age were the independent predictors of
AP, explaining a 16.9% (P,0.0001) and 1.0% (P= 0.008) of its
variation, respectively. In NGT,155 subjects, 1-h post-load
glucose was the main predictor of AP, accounting for a 10.2%
of its variation (P,0.0001). Other independent predictors were
age and BMI explaining another 2.9% (P= 0.002) and 1.3%
(P=0.036) of AP variation. In NGT$155 subjects and IGT
patients, 1-h post-load glucose was the independent predictor of
AP, accounting for the 18.8% (P,0.0001) and 13.7% (P,0.0001)
of its variation in the respective models (Table 3).
1-h post-load glucose was retained as the first independent
predictor of AI in the whole study population and in the groups of
glucose tolerance, explaining a 16.0% (P,0.0001) in the whole
population, 8.3% (P,0.0001) in NGT,155, 24.3% (P,0.0001) in
NGT$155, and 16.1% (P,0.0001) in IGT patients, respectively.
In the whole population, also age, fasting insulin, BMI and gender
entered in the final model that explain the 20.6% of its variation.
In NGT,155 subjects, age, BMI and gender contribute to explain
another 7.3% of AI variation. In IGT group, also fasting insulin
entered in the final model explaining another 4.5% of its variation
(Table 4).
Similarly, 1-h post-load glucose resulted the first independent
predictor of PWV in the whole study population and in the groups
of glucose tolerance, explaining the 25.3% (P,0.0001) in the
whole population, 10.8% (P,0.0001) in NGT,155, 32.6% in
NGT$155 (P,0.0001), and 23% in IGT of its variation,
respectively. In the whole population, hs-CRP, 2-h insulin, age
and 2-h post-load glucose explain another 4.1% of PWV variation.
In NGT,155 subjects, hs-CRP and age explain another 5.0% of
its variation. In NGT$155 subjects, hs-CRP and 2-h insulin were
retained as independent predictors of PWV, explaining another
7.8% of its variation. In IGT group, smoking and total cholesterol
explain another 8.3% of PWV variation (Table 5).
Discussion
Results of this study, conducted in a cohort of never treated
hypertensive and NGT patients, showed that the worsening of
glucose tolerance was associated with an increase of aortic stiffness
and its hemodynamic correlates, such as AP and AI. The clinical
relevance of these data consists in the fact that all these parameters
correlate more closely with intermediate markers of risk for
subsequent cardiovascular events [6]. Similarly, it is well
established that there is a continuous linear relationship between
fasting and post-load plasma glucose concentrations and incident
cardiovascular events, even if 2-hour post-load glycemia has been
identified as the most predictive index of mortality [17]. These
findings are supported by the fact that worsening of glucose
tolerance contributes to the pathogenesis of atherosclerotic
vascular disease more than fasting plasma glucose. In keeping
with this, NGT are considered subjects at lower cardiovascular
risk. However, results of present study clearly demonstrate that in
NGT $155 subjects arterial stiffness, a surrogate end-point for
cardiovascular disease, and aortic hemodynamic parameters are
significantly higher when compared to NGT,155 subjects. In
addition, stepwise multiple regression analysis retained 1-h post-
load plasma glucose as the first independent predictor of PWV in
all groups (Table 4). In particular, it explains the 25.5% in the
whole population, 10.8% of PWV variation in NGT,155 and
32.6% in NGT$155 subjects, respectively.
Previous published results demonstrated an association between
glucose tolerance worsening and PWV [18,19], but at this moment
there are no data demonstrating this relationship between vascular
stiffness and 1-h post-load plasma glucose in NGT subjects. Thus,
our data consent to extend previous knowledge about the
association between glucose tolerance and arterial stiffness,
demonstrating that NGT$155 subjects in comparison with
NGT,155 have a worse metabolic and hemodynamic profile
that contributes to increase their global cardiovascular risk.
Another important finding obtained in this study is that
NGT$155 subjects have both hs-CRP and reduced insulin
sensitivity levels similar to individuals with IGT that are
Table 2. Peripheral and aortic hemodynamic parameters of
the study population according to glucose tolerance status.
All NGT,155 NGT$155 IGT P
Variables (n=584) (n =278) (n =146) (n =160)
Heart rate,
bts/min
6969 7069 6969 6868 0.067
systolic
BP, mmHg
145613 145611 144614 145614 0.711
diastolic
BP, mmHg
9167 9167 9267 9168 0.357
mean
BP, mmHg
10967 10966 10967 10968 0.999
PP, mmHg 54614 54613 53614 54615 0.751
c-systolicBP,
mmHg
133611 131610 134612 134610 0.003
c-diastolic
BP, mmHg
9266 9265 9365 9266 0.143
c-PP, mmHg 40611 38610 42613 42610 ,0.0001
AP, mmHg 11.466.5 9.865.7 12.567.1 13.166.5 ,0.0001
AI, % 27.7612.5 25.1612.4 29.4611.9 30.7612.5 ,0.0001
PWV, m/s 7.562.7 6.761.7 8.463.7 8.262.9 ,0.0001
*x2 test; NGT = normal glucose tolerance; IGT = impaired glucose tolerance;
DM = diabetes mellitus; BMI = body mass index; ISI = insulin sensitivity index;
MS = metabolic syndrome; hs-CRP = high sensitivity C reactive protein; BP =
blood pressure; PP = pulse pressure; c = central; PWV = pulse wave velocity;
AP = augmentation pressure; AI = augmentation index.
doi:10.1371/journal.pone.0044470.t002
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considered at high risk for both T2D and CV disease [20]. The
coexistence of an increased PWV and central hemodynamic
parameters in these subjects contributes to further amplify their
cardiovascular risk profile. In addition, our data consent to
reconsider the concept that NGT subjects are a homogeneous
group with a low cardiovascular risk. Nevertheless, the evidence
that NGT$155 have vascular and metabolic modifications
confirms that the major pathogenetic mechanism promoting
organ damage may be considered the insulin resistance, a clinical
condition that precedes for many years the appearance of T2D. In
keeping with this, some studies have suggested that there may be
an association between insulin sensitivity and arterial stiffness in
individuals without diabetes [21], as well as in young healthy
women [22], diabetic adults [23], and in nondiabetic hypertensive
older adults [24]. This association may be explained by the fact
that insulin resistance is associated with reduced nitric oxide
bioavailability [25] that regulates local arterial distensibility; in
addition, hyperinsulinemia may contribute to the proliferation of
arterial smooth muscle [26]. These factors may lead very early to
arterial stiffness before the development of impaired glucose
tolerance or diabetes. In keeping with this, there are several
mechanisms by which arterial stiffness increases in IGT or diabetic
individuals. It’s well-known that chronic hyperglycemia induces
non-enzymatic glycation of both circulating proteins and those
present in the cellular membrane, leading to the formation of
advanced glycation end products (AGEs). When AGEs accumulate
in the arterial wall, they make irreversible and stable links with
collagen polymers, leading to fibrosis development with increase of
PWV and aortic hemodynamic parameters [27]. Diabetes also
promotes increased lipid oxidation, vasoconstriction, tissue
remodeling, mild vascular inflammation, and sympathetic nervous
system activation, all factors associated with the initiation and
progression of atherosclerosis [27,28]. Finally, it is important to
remark that some of the mechanisms by which arteries stiffen after
exposure to elevations in plasma glucose occur rapidly, such as
endothelial dysfunction that deteriorates during both postprandial
hyperglycemia and hypertriglyceridemia [29,30]. Thus, the most
clinically relevant information, from this study, is that all these
pathological modifications of vascular wall begin early, even in
NGT state that could be considered a false condition at very low
cardiovascular risk.
The prognostic importance of PWV has been attributed to
adverse hemodynamic effects of aortic stiffening, characterized by
an increase in both systolic BP and PP with increased systolic load
and decreased myocardial perfusion pressure. Importantly, this
study also demonstrates a strong relationship between plasma
glucose concentration and arterial stiffening independently of
other known risk cardiovascular factors. Thus, it appears clinically
relevant that impaired glucose regulation, characterised in
particular by post-challenge hyperglycaemia and insulin resistance,
may be considered a readily treatable example of an alternative
pathway promoting vascular stiffness. In keeping with this, present
data have allowed to identify a new early predictor of organ
damage and emphasize the importance to perform an OGTT in
all subjects affected by essential hypertension, paying attention not
only to 2- h but also to 1-h post-load plasma glucose value, which
is more strongly associated with PWV and aortic hemodynamic
parameters.
Table 3. Stepwise multiple regression analysis on augmentation pressure as dependent variable in whole study population and in
NGT subjects with different glucose tolerance status.
All NGT,155 NGT$155 IGT
Partial R2 (%) P Partial R2 (%) P Partial R2 (%) P Partial R2 (%) P
1-h glucose, mg/dl 16.9 ,0.0001 10.2 ,0.0001 18.8 ,0.0001 13.7 ,0.0001
Age, yrs 1.0 0.008 2.9 0.002 – – – –
BMI, Kg/m2 – – 1.3 0.036 – – – –
systolic BP, mmHg – – – – – – 4.5 0.004
Total R2 (%) 17.9 14.4 18.8 18.2
BMI = body mass index; BP = blood pressure.
doi:10.1371/journal.pone.0044470.t003
Table 4. Stepwise multiple regression analysis on augmentation index as dependent variable in whole study population and in
NGT subjects with different glucose tolerance status.
All NGT,155 NGT$155 IGT
Partial R2 (%) P Partial R2 (%) P Partial R2 (%) P Partial R2 (%) P
1-h glucose, mg/dl 16.0 ,0.0001 8.3 ,0.0001 24.3 ,0.0001 16.1 ,0.0001
Age, yrs 2.2 ,0.0001 4.2 ,0.0001 – – – –
Fasting insulin, mU/ml 1.1 0.004 – – – – 4.5 0.003
BMI, Kg/m2 0.7 0.023 1.3 0.035 – –
Gender 0.6 0.045 1.8 0.027 – – – –
Total R2 (%) 20.6 15.6 24.3 20.6
BMI = body mass index.
doi:10.1371/journal.pone.0044470.t004
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